physicians who are tasked with evaluating the clinical and radiographic presentation of children with an intrinsic brainstem mass. Ultimately, the decision regarding whether a presentation is "atypical" enough to require histological confirmation of the diagnosis falls to the treating neurosurgeon and neurooncologist.
In contrast to progress made in the treatment of children with many brain tumors, the prognosis for children with DIPG over the past 2 decades has remained dismal. While therapy for other tumors has been shaped increasingly by understanding of their molecular biology, no comparable progress has been made with DIPG, in which no tissue has been available for advanced tissue analysis (such as microarray analysis). This has led some members of the pediatric neurooncology community to closely examine the parameters for tumor biopsy in patients with suspected DIPG. 3, [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] This examination and debate, and personal observation, led us to hypothesize that there exists variability among pediatric neurosurgeons regarding what qualifies as a radiographically typical DIPG and, furthermore, which tumors merit biopsy. As an investigation of this hypothesis, we completed a survey study to solicit the opinion of the North American pediatric neurosurgical community regarding specific cases of intrinsic brainstem lesions in children.
Methods

Data Reviewed
The study consisted of a review of data from deceased patients, and was therefore exempted from Institutional Review Board review, as verified by the Colorado Multiple Institutional Review Board. The authors reviewed the records of The Children's Hospital of Colorado, University of Colorado Denver, brain tumor program from 1996 through 2009 to identify patients whose radiographic and clinical presentation were considered consistent with DIPG. Initial imaging available through the electronic medical record was reviewed (28 patients). Between 3 and 6 representative MR images from 16 cases were selected to demonstrate a range of the features used to diagnose DIPG on a radiographic basis (Fig. 1) , with variable amounts of inhomogeneity, based on the experience of the senior authors (M.H.H. and N.K.F.). Sixteen cases were selected to offer a balance between generating robust data and overburdening the respondent.
Survey Composition
Using the online service Zoomerang (http://www. zoomerang.com), we created a survey that included a total of 58 questions. There were 48 questions regarding the 16 cases (3 questions per case; Table 1 ). The clinical scenario was the same for each case. It described "a 6 year old with a 4 week history of vague clumsiness progressing to ataxia, then 6 days of a facial droop, contralateral hemiparesis, and dysconjugate gaze. The family strongly wants to know, for sure, what is the diagnosis, and prefers an operation." This wording was chosen to make the wishes of the family unambiguous, thereby removing this variable from the respondent's decision-making process. Each tumor was judged to be either "typical" or "atypical" by each respondent. The respondent was asked if he or she would biopsy the tumor and, if so, what surgical approach would be used. The remaining 10 questions concerned the respon- dent's demographic characteristics, including membership in organized pediatric neurosurgical groups and the year of residency completion, as well as questions regarding the respondent's use of tumor tissue processing and opinions regarding biopsy of DIPG within the context of a multicenter trial.
Survey Distribution
An online link to the survey was e-mailed to all members of the ASPN and the AANS/CNS Joint Section for Pediatric Neurosurgery. A period of 4 months was given for the accrual of responses, from June 28, 2010, to October 27, 2010. For the purposes of statistical analysis, the responses in Table 1 were simplified into 3 categories. Responses a ("Must biopsy") and b ("Would biopsy but would understand if someone else would not") were consolidated into a response category renamed "Would Biopsy." Similarly, responses d ("Would not biopsy but understand how someone else would") and e ("Do not Biopsy") were consolidated into a response category renamed "Would not Biopsy." Response c ("Could be swayed by circumstances: family, oncologist, insurance, availability of operative time, etc.") was left unchanged. For each tumor, we assessed the number of respondents who reported that they would biopsy a tumor that they had considered typical. We likewise assessed the number who would not biopsy a tumor they considered atypical.
Statistical Analysis
Statistical analysis was performed using SAS version 9.2 (SAS Institute Inc.) and Microsoft Excel (2010). The k statistic, used to assess agreement among responders, was computed using the MKAPPA macro (B. Chen et al., unpublished data, 2005). The Pearson correlation coefficient was used to evaluate the association between typicality and whether a responder would biopsy the tumor.
Results
A total of 269 pediatric neurosurgeons received the invitation to complete the survey. Eighty-six responses (32.0%) were received. Questions regarding some tumors were not answered by all respondents. Three tumors (18.8%) received responses from 84 survey participants, 7 tumors (43.8%) received responses from 85 survey participants, and 6 tumors (37.5%) received responses from all 86 survey participants. All calculations were made using the number of respondents to a specific question as the denominator.
Of the 86 respondents, 84 reported their sex and 77 of these were male (91.7%, Table 2 ). Eighty-one percent of respondents reported to be members of the ASPN and 94.2% were members of the AANS/CNS Joint Section for Pediatric Neurosurgery. Almost 80% of respondents reported to be ABPNS certified and 76.5% had completed a fellowship in pediatric neurosurgery.
The year of training completion ( Table 2 ) was distributed evenly, with the exceptions that neurosurgeons who completed residency between 2005 and 2009 were the smallest cohort, while those who completed training prior to 1980 were the largest cohort. There was no significant difference in the rate of tumor biopsy or judgment regarding tumor typicality between respondents from different training completion epochs (data not shown).
Among the 16 tumors, no tumor was judged to be typical or atypical by all respondents. The number of respondents to consider a given tumor typical ranged from 3 (3.5%) to 84 (97.7%; Table 3 , Fig. 2 ). The percentage of respondents who disagreed with the majority opinion regarding whether a tumor qualified as typical ranged from 2.3% to 48.8%, with a median of 28.6%. Of the 16 tumors, ≥ 75% of respondents agreed that the tumor was typical or atypical in 7 cases (43.8%, Fig. 3 ). The k statistic to evaluate respondent consistency with regard to typicality was 0.297 ± 0.0004 (mean ± SEM), implying fair agreement (k statistic: 0 = no agreement, 1.0 = perfect agreement).
Surgeons varied considerably in their willingness to offer biopsy of the tumors, several not biopsying any, and others biopsying almost all of the tumors (Fig. 4) . For each tumor, at least 1 of the respondents who believed the lesion to be typical in appearance would nevertheless biopsy the lesion. The median number of respondents to consider any given lesion typical was 39.5 (45.9%). The median number of those respondents who would biopsy the typical lesion was 2 (5.1%; range 1.2%-66.7%). As the number of respondents who believed a lesion to be typical increased, so did the number of respondents who would not biopsy the lesion despite believing it to be atypical (r = 0.68, p = 0.004). Likewise, for every case, at least 1 of the respondents who believed the lesion to be atypical in appearance would not biopsy the lesion. The median number of respondents to consider any given lesion atypical was 46.5 (54.1%). The median number of those respondents who would not biopsy the atypical lesion was 8.5 (18.3%; range 3.7%-100%). As the number of respondents who believed a lesion to be atypical increased, so did the number of respondents who would biopsy the lesion despite believing it to be typical (r = 0.60, p = 0.014).
We documented the approach selected in any case in which the respondent indicated he or she would biopsy or could be swayed to biopsy (Table 1 , question 2). There were a total of 575 approaches to the biopsy of individual tumors. Among these, transcerebellar stereotactic biopsy was selected in 198 cases (34.4%), transfrontal stereotactic biopsy was chosen in 18 cases (3.1%), open biopsy was selected in 186 cases (32.3%), and open biopsy "with hope to resect as much as seems reasonable" was selected in 173 cases (30.1%). There was no correlation between when the respondent completed training and the surgical approach chosen (data not shown).
In response to a question regarding whether tumor samples are snap frozen, 55 (65.5%) of 84 respondents reported that they always snap freeze, while 24 (28.6%) reported that they sometimes snap freeze tissue (Table 4) . In response to the question: "Would you be willing to biopsy a typical diffuse pontine glioma as a part of a multicenter trial?" 59 (69.4%) of 85 respondents reported that they would, while 26 (30.6%) reported that they would not (Table 4) .
Discussion
In an effort to use MR imaging to differentiate pediatric brainstem tumors radiographically, Barkovich and colleagues 2 pooled retrospective data from 3 studies. They emphasized the importance of a universally accepted radiographic classification system. Albright and colleagues, 1 in the surgical cohort from the Children's Cancer Group protocol CCG-9882, demonstrated that in the context of diffuse intrinsic pontine lesions, the specificity of MR imaging was sufficient to diagnose a brainstem glioma without tissue sampling. As such, the most common practice in pediatric neurosurgery has been to provide therapy without taking on the risk associated with obtaining a histological diagnosis.
Although there are no sanctioned radiographic guidelines for the diagnosis of a DIPG, the most common MR imaging characteristics used to describe a typical DIPG include: 1) an intrinsic, central location involving more than 50% of the axial diameter of the pons; 2) indistinct tumor margins; 3) T1 hypointensity; 4) T2 hyperintensity; 5) irregular, if any, enhancement following Gd administration; and 6) the absence of cystic or exophytic components. Encasement of the basilar artery is another, less consistently referenced characteristic. Using these radiographic parameters, a child who presents with a clinical syndrome that is consistent with a typical DIPG is generally prescribed therapy without histological confirmation of the diagnosis. A child who presents with imaging findings that are not considered to be typical requires histological confirmation of the diagnosis.
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To date, no published study has investigated the consistency of pediatric neurosurgeons in applying widely accepted radiographic parameters for the diagnosis of DIPG. Hayward and colleagues 12 demonstrated a significant amount of interobserver variability among radiologists in the assessment of DIPG response to therapy. It is potentially interesting, therefore, to consider whether similarly qualified practitioners treat the children with a newly diagnosed presumed DIPG in a similar fashion, as one would hope to establish a standard of care. This study demonstrates that, in the majority of children with diffuse intrinsic pontine masses, similarly qualified pediatric neurosurgeons do not reach standard conclusions regarding whether a lesion is typical. For a given case, a median of 28.6% of respondents disagreed with the majority opinion regarding whether a tumor was typical or not. In only 43.8% of cases was there agreement by ≥ 75% of respondents regarding whether a tumor was typical. Additionally, in 18% of cases, surgeons who considered a lesion to be atypical would choose not to biopsy the lesion. This implies that there is considerable variability in the interpretation of presenting imaging and that the resultant surgical care of these patients may also vary substantially. As such, this study presents data that refute the existence of a functional standard of care with regard to the surgical management of these patients.
Although we believe this data to be compelling, this study is subject to potential shortcomings. As a survey, bias results from respondent self-selection. While the response rate of 32.0% was satisfactory, there is a high likelihood that respondents harbored stronger feelings regarding the topic than other members of the population. As such, the sampled group may not accurately represent the entire population of North American pediatric neurosurgeons in every way. In addition, we did not survey nonneurosurgical practitioners, such as radiologists, neurologists, and medical neurooncologists. These physicians also play a significant role in the decision-making process regarding the imaging findings in this patient population. The potential decision-making contributions of these physician as individuals and members of a clinical team could not be accounted for using our study design. Additionally, we acknowledge that we did not define a level of agreement that would be considered adequate to represent a standard of care. We did not do so because we do not believe that a specific level of agreement exists. Lastly, we chose to present a single sample clinical scenario, which was applied to each imaging case. This was done to simplify and shorten the survey process for the respondents and also to focus the study on the interpretation of imaging characteristics rather than an amalgamation of clinical factors. This limits the survey's similarity to the complex clinical reality that physicians encounter with this patient population. Survey data fail to account for differences between how people choose to respond on the survey and what they choose to do in clinical situations, and the changes in an individual's perspective that may result from discussions among radiologists, oncologists, and other neurosurgeons. For nearly 2 decades, the accepted standard for the diagnosis of a typical DIPG has been to rely on radiological imaging without tissue biopsy. This was based on the observation that the diagnostic tools of the time, tissue histology, appeared to have little affect on patient outcome or therapeutic options. It also relied on the assumption that neurosurgeons, oncologists, and radiologists who make the decision on whether to biopsy or not interpret diagnostic MR imaging scans in a uniform manner. The results of this study indicate that this assumption may not be correct.
Meanwhile, we have seen considerable advances in the understanding of the biology of pediatric brain tumors. Children with DIPGs have been systematically excluded from these types of analyses because their tumors have not undergone pathological analysis: without tissue, there can be no biological study. As laboratory investigations of tumor biology fundamentally have changed, and as our understanding is on the verge of shaping therapy for individual patients with their specific tumors, expanding biopsy to patients with DIPGs for the purpose of defining their biological characteristics appears to be widely accepted in the pediatric neurosurgical community.
Conclusions
Although every effort to minimize the risk associated with the management of DIPG must be made, the ideal of diagnosing these lesions based on a radiographic standard appears to be undone by the significant amount of variation in how pediatric neurosurgeons interpret these complex imaging findings and act on them. As such, current practice regarding whether a given tumor demonstrates imaging characteristics that merit a biopsy is not purely objective, but rather subject to the opinion of the treating surgeon.
The inconsistency in diagnosis, and therefore in management, that is noted in these data indicates that no standard of care for the diagnosis of DIPG exists. This finding should be considered as the pediatric neurooncology community ponders how to proceed with clinical trials for children with diffuse intrinsic pontine lesions.
